Screening for a new primary cancer in patients with existing metastatic cancer: a retrospective cohort study
MC Cheung, J Tinmouth, PC Austin… - … Open Access Journal, 2018 - cmajopen.ca
Background: Cancer screening aims to detect malignant disease early in its natural history
when interventions might improve patient outcomes. Such benefits are unclear when …
when interventions might improve patient outcomes. Such benefits are unclear when …
Screening for new primary cancers in patients with metastatic breast cancer: a provincial analysis of the Choosing Wisely Canada recommendations
M Tesch, K Laing - Current Oncology, 2019 - mdpi.com
Introduction: Patients with metastatic cancer have a decreased life expectancy, and with
screening and surveillance for new primary cancers, they run the risk of immediate harm …
screening and surveillance for new primary cancers, they run the risk of immediate harm …
Screening for new primary cancers in patients with metastatic breast cancer: A provincial analysis of the Choosing Wisely Canada recommendations.
ME Tesch, KE Laing - 2018 - ascopubs.org
e18817 Background: As part of the broader Choosing Wisely Canada campaign, a list was
published in May 2015 of practices in oncology that are commonly performed despite …
published in May 2015 of practices in oncology that are commonly performed despite …
Choosing Wisely in oncology: Screening for a new primary cancer in patients with metastatic disease.
295 Background: The Choosing Wisely Canada (CWC) campaign aims to start
conversations about unnecessary treatments and procedures in order to improve quality of …
conversations about unnecessary treatments and procedures in order to improve quality of …
Cancer screening among patients with advanced cancer
CS Sima, KS Panageas, D Schrag - Jama, 2010 - jamanetwork.com
Context Cancer screening has been integrated into routine primary care but does not benefit
patients with limited life expectancy. Objective To evaluate the extent to which patients with …
patients with limited life expectancy. Objective To evaluate the extent to which patients with …
Identifying and screening patients at risk of second cancers
VG Vogel - Cancer Epidemiology Biomarkers & Prevention, 2006 - AACR
Background: The average age of the US population is increasing, and cancer incidence
increases with age. Both improved early detection of first malignancies and effective primary …
increases with age. Both improved early detection of first malignancies and effective primary …
Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent
RG Salloum, MC Hornbrook, PA Fishman… - Cancer, 2012 - Wiley Online Library
BACKGROUND: Evidence‐based guidelines recommend routine surveillance, including
office visits and testing, to detect new and recurrent disease among survivors of breast and …
office visits and testing, to detect new and recurrent disease among survivors of breast and …
One stop screening for multiple cancers: The experience of an integrated cancer prevention center
T Sella, B Boursi, A Gat-Charlap, I Aroch… - European Journal of …, 2013 - Elsevier
BACKGROUND: Cancer is a leading cause of mortality worldwide. Screening is a key
strategy for reducing cancer morbidity and mortality. METHODS: We aimed to describe the …
strategy for reducing cancer morbidity and mortality. METHODS: We aimed to describe the …
[HTML][HTML] Screening for new primary cancers in cancer survivors compared to non-cancer controls: a systematic review and meta-analysis
Purpose The goal of this study was to synthesize evidence comparing cancer screening
receipt between cancer survivors and non-cancer controls by conducting a systematic …
receipt between cancer survivors and non-cancer controls by conducting a systematic …
Screening history and 7-year survival in 32,099 colorectal cancer patients: a population-based cohort study
BY Hsiao, CJ Chiang, YW Yang, LJ Lin… - Clinical …, 2023 - Taylor & Francis
Background It is unclear whether colorectal cancer screening history, regardless of stage, is
an independent predictor of survival, and if the screening advantage persists after diagnosis …
an independent predictor of survival, and if the screening advantage persists after diagnosis …